Deep 6 AI's Cohort Builder is a software tool researchers can use to assist with identifying patients for clinical trials. It allows research staff to search structured and unstructured data in the EMR; looking at millions of documents in a matter of seconds. Once you’ve...
Hometown heroes – Deep 6 AI was recently named one of Built in LA’s 50 Startups to Watch in 2019. The award, given to innovative companies “poised to make a real impact on the Southern California tech scene this year and beyond,” highlights our everyday work towards...
AI Pharma In Innovation called out Deep 6 as a company that is tackling one of the hardest problems in medical research. Did you know that 90% of drugs that reach clinical stage development never make it to FDA approval and commercialization? And that of the...
Created specifically for multi-site research collaboration, CROs, and study sponsors, our Patient Panorama offers a real-time view of aggregate patient population data across numerous sites. This allows researchers to work together across health systems and helps sponsors with their trial design and site selection, based on real-time aggregated data and effortless site feedback. Starting your next clinical...
This fall, our Chief of Staff, Alvin Tam, met with Australian Prime Minister Scott Morrison and Minister of Health Greg Hunt to discuss the creation of a global research collaboration and clinical trials network. Deep 6 AI attended as part of a Texas Medical Center delegation to expand its BioBridge platform with Australia. We are proud to provide the...
Canada Talks Pharma: How Artificial Intelligence Is Transforming Clinical Trial Recruitment Toronto, May 15, 2018 at 9:30am Deep 6 AI presented at Canada Talks Pharma, “How Artificial Intelligence Is Transforming Clinical Trial Recruitment,” on May 15, at 9:30am in Toronto. [vc_row][vc_column width='2/3']Wout Brusselaers, CEO and co-founder of Deep 6 AI,...
Deep 6 demos at ACRP 2018 WASHINGTON, DC. (April 27, 2018) – We just had our first booth presence at the ACRP Expo 2018., a premier continuing education and networking event for clinical research professionals. With over 60 sessions and workshops designed to improve the quality...
Deep 6 discussed the ROI of AI for Clinical Trials at Bridging Clinical Research NATIONAL HARBOR, Maryland. (April 4, 2018) – Eric Gildenhuys, Deep 6 AI Vice President of Business Development, presented on "Creating Synergies Between Health Care and Clinical Trial Data Through Technology" at the 2018...
Wout Brusselaers to Speak at HIMSS18 on Finding the Return on Investment of Artificial Intelligence [caption id="attachment_17174" align="alignright" width="175"] Bobbie J Rimel, MD, Cedars-Sinai Medical Center[/caption] [caption id="attachment_17173" align="alignright" width="175"] Wout Brusselaers, CEO, Deep 6 AI[/caption] PASADENA, Calif. (February 13, 2018) – HIMSS has named Wout Brusselaers, chief...
Texas Medical Center selects Deep 6 AI for accelerator Deep 6 AI is one of 23 digital health startups participating in the Texas Medical Center Accelerator (TMCx). The Texas Medical Center is the world's largest medical center with 58 member institutions and a central research institute...